Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: Results from a 3-month prospective open-label study

Martien Wampers, Linda Hanssens, Ruud van Winkel, Adrian Heald, Julien Collette, Joseph Peuskens, Jean-Yves Reginster, Andre Scheen, Marc De Hert*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)17-26
JournalEuropean Neuropsychopharmacology
Volume22
Issue number1
DOIs
Publication statusPublished - Jan 2012

Keywords

  • Adiponectin
  • Antipsychotic
  • Diabetes
  • Metabolic side-effects
  • Metabolic syndrome
  • Schizophrenia

Cite this